Full-Time

Quality Engineer II

Validation

Posted on 2/11/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

No salary listed

Mid

Grayson, GA, USA

Minimum of 4 days of in-office presence required per week.

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor's degree or equivalent experience + education
  • Minimum of 2-3 years relevant work experience: validations in an FDA regulated environment, writing protocols, performing & writing reports
  • Advanced computer skills, including Microsoft Office Suite applications
  • Strong communication and interpersonal skills
  • Ability to effectively communicate technical information verbally and in writing to peers and senior management
Responsibilities
  • Ensure compliance with regulatory requirements for both domestic and international markets; participates in U.S. FDA inspections as required
  • Participate in multi-functional teams responsible for developing and implementing robust quality assurance systems
  • Apply statistical techniques and other problem solving methods to identify root causes and implement effective corrective actions
  • Lead investigations related to product complaints, customer notifications, and nonconformances
  • Develop test methods, specifications, and other technical documents
  • Maintain quality records and documentation including CAPAs, audit findings, training, and investigation reports
  • Provide guidance and training to production personnel on quality issues
  • Review and approve process changes (PCN) prior to implementation ensuring the impact on product quality and safety is understood and controlled
  • Monitor key performance indicators and metrics reporting results to management
  • Represent Quality department on new product development projects
Desired Qualifications
  • Master's degree preferred
  • Experience in GMP/GDP environment highly desirable

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which provides safe collection and transport products for diagnostic specimens; and BD Interventional, which offers devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

INACTIVE